| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 1995 | Arsenic and ischemic heart disease in the blackfoot disease-endemic area | Lin, L. J.; Horng, S. F.; Liaw, K. F.; Hsueh, Y. M.; Chiou, H. Y.; Tseng, C. H.; Tai, T. Y.; Chen, C. J. | Chinese J Public Health 14, 502-511 | | | |
| 2008 | Arsenic cancer risk posed to human health in Taiwan from tilapia consumption | Liao, C. M.; Shen, H. H.; Lin, T. L.; Chen, S. C.; Chen, C. L.; Hsu, L. I.; Chen, C. J. | Ecotoxicol Environ Safe 70, 27-37 | | | |
| 1999 | Arsenic exposure and peripheral vascular disease | Tseng, C. H.; Chong, C. K.; Chiou, H. Y.; Hsueh, Y. M.; Chen, C. J. | Chin J Public Health 18 suppl 1, 155-162 | | | |
| 2017 | Arsenic Exposure From Drinking Water and the Incidence of CKD in Low to Moderate Exposed Areas of Taiwan: A 14-Year Prospective Study | Hsu, LI; Hsieh, FI; Wang, YH; Lai, TS; Wu, MM; Chen, CJ ; Chiou, HY; Hsu, KH | American journal of kidney diseases : the official journal of the National Kidney Foundation 70(6), 787-797 | | | |
| 2008 | Arsenic exposure, urinary arsenic speciation and the incidence of urothelial carcinoma: a twelve-year follow-up study | Huang, Y. K.; Huang, Y. L.; Hsueh, Y. M.; Yang, M. H.; Wu, M. M.; Chen, S. Y.; Hsu, L. I.; Chen, C. J. | Cancer Cause Control 19,829-839 | | | |
| 2005 | Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan | Tseng, C. H.; Huang, Y. K.; Huang, Y. L.; Chung, C. J.; Yang, M. H.; Chen, C. J.; Hueh, Y. M. | Toxicol Appl Pharmacol 206, 299-308 | | | |
| 2010 | Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan | Chen, CL; Chiou, HY; Hsu, LI; Hsueh, YM; Wu, MM; wang, YH; Chen, CJ | Cancer Epidemiol Biomark Prev 19:101-110 | | | |
| 2007 | Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan | Huang, Y. K.; Tseng, C. H.; Huang, Y. L.; Yang, M. H.; Chen, C. J.; Hsueh, Y. M. | Toxicol Appl Pharmacol 218, 135-142 | | | |
| 2008 | Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas | Huang, S. K.; Chiu, A. W.; Pu, Y. S.; Huang, Y. K.; Chung, C. J.; Tsai, H. J.; Yang, M. H.; Chen, C. J.; Hsueh, Y. M. | Urol Int 80, 405-412 | | | |
| 2009 | Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma | Huang, SK; Chiu, AW; Pu, YS; Huang, YK; Chung, CJ; Tsai, HJ; Yang, MH; Chen, CJ; Hsueh, YM | Urol Int 82,227-234 | | | |
| 2000 | Arsenic methylation capacity and skin cancer | Yu, R. C.; Hsu, K. H.; Chen, C. J.; Froines, J. R. | Cancer Epidemiol Biomarker Prev 9, 1259-1262 | | | |
| 1997 | Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan | Chiou, H. Y.; Hsueh, Y. M.; Hsieh, L. L.; Hsu, L. I.; Hsu, Y. H.; Hsieh, F. I.; Wei, M. L.; Chen, H. C.; Yang, H. T.; Leu, L. C.; Chu, T. H.; Chen-Wu, C.; Yang, M. H.; Chen, C. J. | Mutat Res 386, 197-207 | | | |
| 2012 | Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in arseniasis endemic area of southwestern Taiwan | Chen, JW; Wang, SL; Wang, YH; Sun, CW; Huang, YL; Chen, CJ; Li, WF | Chemosphere 88(4), 432-438 | | | |
| 2010 | Arsenic-induced QT dispersion is associated with atherosclerotic diseases and predicts long-term cardiovascular mortality in subjects with previous exposure to arsenic: a 17-year follow-up study | Wang, CH; Chen, CL; Hsiao, CK; Hsu, LI; Chiou, HY; Hsueh, YM; Wu, MM; Chen, CJ | Cardiovasc Toxicol 10:17-26 | | | |
| 1994 | Arsenic-related Bowen's disease and paraquat-related skin lesions show no detectable ras and p53 gene mutations | Hsieh, L. L.; Chen, H. J.; Hsieh, J. T.; Jee, S. H.; Chen, C. J. | Cancer Lett 86, 59-65 | | | |
| 2012 | Arsenical skin lesions predict adverse arsenic-induced health effects (response to invited commentary) | Hsu, LI; Chen, CJ | Am J Epidemiol | | | |
| 2016 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update | Sarin, SK; Kumar, M; Lau, GK; Abbas, Z; Chan, HLY; Chen, CJ; Chen, DS; Chen, HL; Chen, PJ; Chien, RN; Dokmeci, AK; Gane, Ed; Hou, JL; Jafri, W; Jia, J; Kim, JH; Lai, CL; Lee, HC; Lim, SG; Liu, CJ; Locarnini, S; Mahtab, M Al; Mohamed, R; Omata, M; Park, J; Piratvisuth, T; Sharma, BC; Sollano, J; Wang, FS; Wei, L; Yuen, MF; Zheng, SS; Kao, JH | Hepatol Int 10(1), 1-98 | | | |
| 2012 | ASK1 promotes apoptosis of normal and malignant plasma cells | Lin, F. -R.; Huang, S. -Y.; Hung, K. -H.; Su, S. -T.; Chung, C. -H.; Matsuazwa, A.; Hsiao, M.; Ichijo, H.; Lin, K. -I | Blood 120 (5), 1039-1047 | | | |
| 2012 | ASK1 promotes apoptosis of normal and malignant plasma cells. | Lin, FR; Huang, SY; Hung, KH; Su, ST; Chung, CH; Matsuzawa, A; Hsiao, M; Ichijo, H; Lin, KI | Blood 120(5), 1039-1047 | | | |
| 1998 | Assembly of oligosaccharide libraries with a designed building block and an efficient orthogonal protection-deprotection strategy | Wong, C. H.; Ye, X. S.; Zhang, Z. Y. | J Am Chem Soc 120, 7137-7138 | | | |
